FIDAL advise venture capital and growth investors, corporates and high-growth companies across a wide range of small- and mid-cap transactions. Particularly active in the energy transition, healthcare, life sciences, industrials and technology sectors, the practice is is led by Sabrina Bol, who also brings related expertise of mergers & acquisitions and corporate transactions.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘Attentive and pragmatic.’
Key clients
- MATERR’UP
- UNEXO
- OUEST CROISSANCE
- BNP DEVELOPPEMENT
- GO CAPITAL
- DEMETER
- BPI FRANCE
- MER INVEST
- CSBT ENVIRONNEMENT
- INSIDE THERAPEUTICS
- OCCTE
- GSO
Work highlights
Advised MATERR’UP, a company specialising in the production of low-carbon concrete from clay cement, on its capital increase backed by Eurazeo, the European Innovation Council Fund (EIC), UI Investissement, IRDI and Aquitaine Création Investissement.
Advised OCCTE, GSO Innovation and Finorpa on a minority investment in Genoskin, a company specialising in skin biology and immunology, including legal, tax and labour law due diligence, as well as the drafting and negotiation of the investment documentation.
Advised Unexo, Ouest Croissance and BNP Développement on the acquisition of a minority stake in Guyot Environnement, a metal recycling company, through the issuance and acquisition of shares and convertible bonds.
Practice head
Sabrina Bol